The Cancer Ecosystem:
from Research to Pathology & Treatment
Preliminary Programme
02 MAY 2019
09.00 Welcome Session, Manuel Sobrinho-Simões, i3S/ Ipatimup & Mário Barbosa, i3S
Session 1: Microbiome in Cancer
9.15-9.45 Role of the gut microbiome in causing, detecting and treating colorectal cancer
Paul O’Toole, School of Microbiology, University College Cork, Ireland
9.45-10.15 Giandomenica Iezzi, Department of Surgery, Ente Ospedaliero Cantonale and Faculty of Biomedical Science, Università della Svizzera Italiana, Lugano, Switzerland
10.15-10.45 Coffee-break
10.45-11.15 Gut microbiota, can we improve the outcome of cancer immunotherapy
Meriem Messaoudene, Centre de Recherche du Centre Hospitalier de l’Universite de Montreal, Canada
11.15-11.30 Selected Talk
SPECIAL SESSION: Science and Society
12.00-13.00 Lunch
13.00-14.30 Speed Talks
Session Session 2: Tumour Microenvironment
14.30-15.00 The crosstalk between stem-like cancer cells and the tumor microenvironment
Joana Paredes, i3S – Instituto de Inovação em Saúde / Ipatimup, Portugal J
15.00-15.30 Metabolic interactions in chronic lymphocytic leukemia
Dimitrios Mougiakakos, Department of Medicine 5 – Hematology and Clinical Oncology, University of Erlangen, Germany
15.30-16.00 Coffee-break
16.00-16.30 Neoadjuvant chemotherapy elicits a pro-metastatic cascade through extracellular vesicles
Ioanna Keklikoglou, Swiss Institute for Experimental Cancer Research, School of Life Sciences, École Polytechnique Fédérale de Lausanne, Switzerland
16.30-16.45 Selected Talk
20.00 Meeting Dinner
03 MAY 2019
Session 3: Inflammation and Cancer
9.00-9.30 “Inflammation and homeostasis” to understand “Inflammation and cancer”
Francisco Real, Spanish National Cancer Research Centre / Universitat Pompeu Fabra, Spain
09.30-10.00 Erwin Wagner
10.00-10.30 Coffee Break
10.30-11.00 On the role of innate and adaptive immune cells in fatty liver disease and subsequent liver cancer
Mathias Heikenwälder,Chronic Inflammation and Cancer, German Cancer Research Center, Heidelberg, Germany
11.00-11.15 Selected Talk
11.15-12.30 Speed talks
12.30-14.00 Lunch and Poster viewing
Session 4: Immunotherapy
14.00-14.30 The Exosomes in Immune Suppression and Tumor Progression
Wei Guo, Department of Biology, School of Arts & Sciences, University of Pennsylvania, USA
14.30-15.00 Neoadjuvant immunotherapy – the pathway to biomarker identification and personalized therapy
Christian Blank, Netherlands Cancer Institute, the Netherlands
15.00-15.30 Coffee-break
16.00-16.30 Signal Finding Platform trials: optimizing drug development
Pablo Martinez Rodriguez, Medimmune, LLC, USA
16.30-16.45 Selected Talk
Adjourn
